Chemclin Diagnostics Co., Ltd.
SHH: 688468.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Yanling Huang
- Employees
- 731
- Headquarters
- Beijing, China
- IPO year
- 2021
- Market cap
- CN¥3.1B
- Website
- https://www.chemclin.com
Loading 688468…
Loading profile data…Frequently asked questions about 688468
What does Chemclin Diagnostics Co., Ltd. (688468.SS) do?
Chemclin Diagnostics Co., Ltd. engages in the research and development, production, and sale of clinical immune chemiluminescence diagnostic testing reagents and instruments. Its products include LiCA series of diagnostic reagents based on photoinduced chemiluminescence method, and CC series diagnostic reagents and instruments based on enzymatic...
Where does 688468.SS trade?
Chemclin Diagnostics Co., Ltd. (688468.SS) trades on the Shanghai Stock Exchange.
What sector is 688468.SS in?
Chemclin Diagnostics Co., Ltd. (688468.SS) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Chemclin Diagnostics Co., Ltd.?
Yanling Huang is the chief executive officer of Chemclin Diagnostics Co., Ltd. (688468.SS).
Where is Chemclin Diagnostics Co., Ltd. headquartered?
Chemclin Diagnostics Co., Ltd. is headquartered in China.
Does 688468.SS pay a dividend?
Yes — Chemclin Diagnostics Co., Ltd. (688468.SS) paid a trailing twelve-month dividend of CNY 0.13 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 688468.SS go public?
Chemclin Diagnostics Co., Ltd. (688468.SS) completed its initial public offering in 2021.